Ryan Bitton, PharmD, MBA, and Frank J. Palella, MD, discuss facts about the implementation of USPSTF guidelines for HIV PrEP therapy. Ryan Haumschild, PharmD, MS, MBA: Thank you. It’s such a complex ...
Sean E. Bland, JD, reviews the USPSTF guidelines as support to access HIV PrEP therapy and Ryan Bitton, PharmD, MBA, shares a payer perspective on the implications of these guidelines. Ryan Haumschild ...
We are writing in response to “The Task Force’s Latest PrEP Recommendation For HIV Is Just More Of The Same” by Richard Hughes IV, published in Forefront on November 1, 2023. We share the author’s ...
In their recent response to my earlier article, Amy Killelea and Jeremiah Johnson take a position that overlooks patient access concerns and undermines innovation toward newer and better forms of PrEP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results